Details for New Drug Application (NDA): 203106
✉ Email this page to a colleague
NDA 203106 describes KLOR-CON, which is a drug marketed by Upsher Smith Labs and is included in four NDAs. It is available from five suppliers. Additional details are available on the KLOR-CON profile page.
The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 203106
| Tradename: | KLOR-CON |
| Applicant: | Upsher Smith Labs |
| Ingredient: | potassium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 8MEQ | ||||
| Approval Date: | Jul 10, 2015 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
| Approval Date: | Jul 10, 2015 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
